Literature DB >> 30927189

The forensic significance of pseudomesotheliomatous adenocarcinoma of the lung.

John M Kennedy1,2.   

Abstract

Pseudomesotheliomatous carcinomas (PMC) are rare tumors that clinically, macroscopically, and sometimes histologically resemble malignant pleural mesotheliomas. We report a case of a 91 year woman who was found to have diffuse nodular pleural thickening and a lung mass during a workup for persistent cough. She declined rapidly and died before a histologic diagnosis could be made. Postmortem examination revealed a tumor that diffusely involved the pleural surface with local extension into the chest wall, pericardium, and diaphragm along with a concurrent lung mass. Histologic examination showed poorly-differentiated cells predominantly arranged in sheets, cords, and nests with focal glandular differentiation. An immunohistochemical panel of calretinin, WT1, BEREP4, MOC31, and TTF1 confirmed the diagnosis of primary lung adenocarcinoma. The macroscopic, histologic, and immunohistochemical features used to distinguish metastatic and primary lung adenocarcinoma from epithelioid malignant mesothelioma are discussed. The distinction of malignant mesothelioma from pseudomesotheliomatous carcinoma is important for medicolegal reasons regarding asbestos related compensation claims.

Entities:  

Keywords:  Histopathology; Lung adenocarcinoma; Mesothelioma; Pseudomesotheliomatous adenocarcinoma

Mesh:

Substances:

Year:  2019        PMID: 30927189     DOI: 10.1007/s12024-019-00110-9

Source DB:  PubMed          Journal:  Forensic Sci Med Pathol        ISSN: 1547-769X            Impact factor:   2.007


  13 in total

1.  Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.

Authors:  William D Travis; Elisabeth Brambilla; Allen P Burke; Alexander Marx; Andrew G Nicholson
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

2.  Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile.

Authors:  Javier Pardo; Wenceslao Torres; Ana Martinez-Peñuela; Angel Panizo; Enrique de Alava; Juan Luis García
Journal:  Ann Diagn Pathol       Date:  2007-08       Impact factor: 2.090

3.  Legal claims for malignant mesothelioma: dealing with all cases.

Authors:  Sjoukje van der Bij; Paul Baas; Marc J van de Vijver; Bas A J M de Mol; Jacobus A Burgers
Journal:  Lung Cancer       Date:  2013-02-15       Impact factor: 5.705

4.  Pseudomesotheliomatous carcinoma involving pleura and peritoneum: A clinicopathologic and immunohistochemical study of three cases.

Authors:  I A Shah; J R Salvatore; T Kummet; O S Gani; L A Wheeler
Journal:  Ann Diagn Pathol       Date:  1999-06       Impact factor: 2.090

5.  Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.

Authors:  Kyuichi Kadota; Kei Suzuki; Camelia S Sima; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2011-05       Impact factor: 15.609

6.  Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.

Authors:  Francine Baumann; Erin Flores; Andrea Napolitano; Shreya Kanodia; Emanuela Taioli; Harvey Pass; Haining Yang; Michele Carbone
Journal:  Carcinogenesis       Date:  2014-11-07       Impact factor: 4.944

7.  Synchronous diffuse malignant mesothelioma and carcinomas in asbestos-exposed individuals.

Authors:  R L Attanoos; D H Thomas; A R Gibbs
Journal:  Histopathology       Date:  2003-10       Impact factor: 5.087

8.  New Markers for Separating Benign From Malignant Mesothelial Proliferations: Are We There Yet?

Authors:  Andrew Churg; Brandon S Sheffield; Francoise Galateau-Salle
Journal:  Arch Pathol Lab Med       Date:  2015-08-19       Impact factor: 5.534

9.  'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff.

Authors:  R L Attanoos; A R Gibbs
Journal:  Histopathology       Date:  2003-11       Impact factor: 5.087

Review 10.  Malignant Mesothelioma Diagnosis.

Authors:  Qudsia Arif; Aliya N Husain
Journal:  Arch Pathol Lab Med       Date:  2015-08       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.